| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |